Browse by Title

Type here to filter the list

O
OAC with LAAC: A New Potential Paradigm

Kenneth A. Ellenbogen, MD – VCU School of Medicine ### 902055###Speaker###Professor###VCU School of Medicine###
Speaker: Kenneth A. Ellenbogen, MD – VCU School of Medicine
###
One of The Worst Nightmares Ever

Simone Zecchino, MD ### 2228570###Speaker#########
Speaker: Simone Zecchino, MD
###
One Size Doesn't Fit All: Right-Sizing the SCAI SHOCK Classification to Devices and Techniques

Srihari S. Naidu, MD, FSCAI – Westchester Medical Center ### 163225###Speaker###Director, Cath Labs and HCM Program###Westchester Medical Center###
Speaker: Srihari S. Naidu, MD, FSCAI – Westchester Medical Center
###
One Year Results Of The Deeper Limus Trial: The Bare Temporary Spur Stent System In Combination With A Sirolimus Coated Balloon

Marianne Brodmann, MD – Medical University Graz ### 163043###Speaker###Substitue Head of Divsion of Angiology, Medical University Graz###Medical University Graz###
Speaker: Marianne Brodmann, MD – Medical University Graz
###
One Year Results Of The Deeper Ous Trial: The Bare Temporary Spur Stent System Followed By A Paclitaxel-coated Balloon

Thomas Zeller, MD (he/him/his) – Universitäts-Herzzentrum Freiburg - Bad Krozingen ### 163356###Speaker###Director Department Angiology###Universitäts-Herzzentrum Freiburg - Bad Krozingen###
Speaker: Thomas Zeller, MD (he/him/his) – Universitäts-Herzzentrum Freiburg - Bad Krozingen
### he/him/his
One-Year Outcomes from a Randomized Comparison of Transcatheter Edge-to-Edge Repair Systems for Degenerative MR: The CLASP IID Trial and Registry

Firas Zahr, MD – OHSU ### 1520151###Speaker###Director, Interventional Cardiology###OHSU###
Speaker: Firas Zahr, MD – OHSU
###
One-Year Outcomes in the Navitor IDE Study Utilizing the Intra-Annular, Self-Expandable Navitor Transcatheter Aortic Heart Valve

Paul D. Mahoney, MD, FACC, FSCAI – ECU Health ### 478297###Speaker###Chief, Interventional Cardiology, Director, Structural Heart Program###ECU Health###
Speaker: Paul D. Mahoney, MD, FACC, FSCAI – ECU Health
###
One-year Real-world Outcomes For Patients Undergoing Transcatheter Mitral Valve Repair: The Gulf Mteer Registry (gulf Mitral Transcatheter Edge To Edge Repair

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital ### 256841###Speaker###Catheterization Laboratory Director & Deputy Head of Cardiology###King Fahd Armed Forces Hospital###
Speaker: Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital
###
Open TAAA Techniques and Pearls

Rana O. Afifi, MD (she/her/hers) – McGovern Medical School at UTHealth ### 2199657###Speaker###Associate Professor###McGovern Medical School at UTHealth###
Speaker: Rana O. Afifi, MD (she/her/hers) – McGovern Medical School at UTHealth
### she/her/hers
Operations Working Group

Ernest Spitzer, MD – Cardialysis B.V. ### 1299623###Speaker###Chief Executive Officer###Cardialysis B.V.###
Speaker: Ernest Spitzer, MD – Cardialysis B.V.
###
OPN Balloon for Calcium Plaque Modification in Native Coronary Arteries

Natalia Pinilla, MD, PhD (she/her/hers) – McMaster University ### 1429015###Speaker###Assistant Professor / Interventional Cardiologist###McMaster University###
Speaker: Natalia Pinilla, MD, PhD (she/her/hers) – McMaster University
### she/her/hers
Optimal Quantitation of Mitral Regurgitant Volume by Echo

Anthony DeMaria, MD – University of California, San Diego ### 431332###Speaker###Judy and Jack White Chair in Cardiology###University of California, San Diego###
Speaker: Anthony DeMaria, MD – University of California, San Diego
###
Optimization of Calcified LM Intervention - Is DK Crush the Best Strategy?

Shaoliang Chen, MD – Nanjing First Hospital,Nanjing Medical University ### 190734###Speaker###Secretary###Nanjing First Hospital,Nanjing Medical University###
Speaker: Shaoliang Chen, MD – Nanjing First Hospital,Nanjing Medical University
###
OPTIMIZATION OF THERAPY FOR CAD PATIENTS WITH PHARMACOTHERAPY [CME] – Supported Through an Educational Grant by Chiesi USA, Inc.

Marc Cohen, MD (he/him/his) – Newark Beth Israel Med Ctr ### 163060###Moderator###Chair of Medicine###Newark Beth Israel Med Ctr###
Moderator: Marc Cohen, MD (he/him/his) – Newark Beth Israel Med Ctr
### he/him/his @@@ C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Moderator###Professor of Medicine###Beth Israel Deaconess Medical Center###
Moderator: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
### @@@ Neal S. Kleiman, MD, FACC, MSCAI – Houston Methodist DeBakey Heart and Vascular Center ### 163169###Moderator###Medical Director, Cardiac Catheterization Laboratories###Houston Methodist DeBakey Heart and Vascular Center###
Moderator: Neal S. Kleiman, MD, FACC, MSCAI – Houston Methodist DeBakey Heart and Vascular Center
###
Ostial CTO

Jason Wollmuth, MD – Providence Heart and Vascular Institute ### 692636###Speaker###Interventional Cardiologist###Providence Heart and Vascular Institute ###
Speaker: Jason Wollmuth, MD – Providence Heart and Vascular Institute
###
Our Best/Worst TAVR Complications and How We Worked Around Them

Fayaz Shawl, MD, FACC, FACP, FSCAI – Adventist HeathCare WhiteOak Medical Center ### 163291###Speaker###Director, Interventional Cardiology###Adventist HeathCare WhiteOak Medical Center ###
Speaker: Fayaz Shawl, MD, FACC, FACP, FSCAI – Adventist HeathCare WhiteOak Medical Center
###
Outcome After Percutaneous Coronary Intervention Of Drug-eluting- Vs Bare Metal In-stent Restenosis: A Segment-level Nationwide Analysis From SCAAR

Sacharias von Koch, MD – Department of Cardiology, Skåne University Hospital, Lund Sweden ### 2234295###Speaker###PhD student in cardiology###Department of Cardiology, Skåne University Hospital, Lund Sweden###
Speaker: Sacharias von Koch, MD – Department of Cardiology, Skåne University Hospital, Lund Sweden
###
Outcomes Of Primary Percutaneous Coronary Intervention For STEMI With Versus Without SCAD

Abhishek Chaturvedi, MD (he/him/his) – Georgetown University MedStar Washington Hospital Center ### 2166337###Speaker###Interventional Cardiology Fellow###Georgetown University MedStar Washington Hospital Center###
Speaker: Abhishek Chaturvedi, MD (he/him/his) – Georgetown University MedStar Washington Hospital Center
### he/him/his
Outcomes of Transcatheter Mitral Valve Replacement with SAPIEN Transcatheter Heart Valve for Degenerated Bioprostheses and Failed Annuloplasty Rings: A Meta-Analysis

Joe Aoun, MD – Houston Methodist DeBakey Heart & Vascular Center ### 2228880###Speaker###Interventional Cardiology and Structural Heart Disease###Houston Methodist DeBakey Heart & Vascular Center###
Speaker: Joe Aoun, MD – Houston Methodist DeBakey Heart & Vascular Center
###
Overview Discussion, Comments & Next Steps

Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Panel Moderator###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Panel Moderator: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Panel Moderator###Director Office of CV Devices###U.S. Food and Drug Administration###
Panel Moderator: Bram Zuckerman, MD – U.S. Food and Drug Administration
### @@@ Dominic Allocco, MD, MS – Boston Scientific ### 914909###Panel Discussant###Vice President, Clinical###Boston Scientific###
Panel Discussant: Dominic Allocco, MD, MS – Boston Scientific
### @@@ Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute ### 457703###Panel Discussant###Director, Interventional Cardiology and Interventional Research and Innovation###Inova Heart & Vascular Institute###
Panel Discussant: Wayne Batchelor, MD, MHS – Inova Heart & Vascular Institute
### @@@ Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration ### 163094###Panel Discussant###Chief Medical Officer, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Panel Discussant: Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ C. Michael Gibson, MD – Beth Israel Deaconess Medical Center ### 163112###Panel Discussant###Professor of Medicine###Beth Israel Deaconess Medical Center###
Panel Discussant: C. Michael Gibson, MD – Beth Israel Deaconess Medical Center
### @@@ Graeme Hickey ### 2273347###Panel Discussant#########
Panel Discussant: Graeme Hickey
### @@@ Ernest Spitzer, MD – Cardialysis B.V. ### 1299623###Panel Discussant###Chief Executive Officer###Cardialysis B.V.###
Panel Discussant: Ernest Spitzer, MD – Cardialysis B.V.
### @@@ Rebecca Torguson, MPH – FDA ### 163318###Panel Discussant###Division Director###FDA###
Panel Discussant: Rebecca Torguson, MPH – FDA
###
Overview of FDA Draft Guidance on DEI

Brittany Caldwell ### 2273349###Speaker#########
Speaker: Brittany Caldwell
###
Overview of the CSRC Shock Program 2017-2024

Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Speaker###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Speaker: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his
Overview of the FDA DEI Draft Guidance

Brittany Caldwell ### 2273349###Speaker#########
Speaker: Brittany Caldwell
###